🔗 Share this article

A shadow market for unapproved weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers market the drug there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and consumer regulations, risking penalties, legal action or prison.

Service Response and Material Removal

Based on the social media company, the platform has removed violative content and prohibited associated keywords and search suggestions. The organization stated it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also discovered communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, populated with photos of slimming results, glowing reviews and step-by-step instructions for mixing or administering at residence.

Within moments of entering one community, a vendor shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, posts display black plastic packages with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When asked how long a injector should last, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram stated it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Although the research behind retatrutide is sound, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously seen patients injured by personal administration from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to possibly serious health risks”.